GH Research PLC Ordinary Shares (GHRS)
GH Research PLC is a clinical-stage biopharmaceutical company focused on developing innovative psychedelics and neuromodulators for mental health and neurological disorders. Headquarters in Ireland, the company specializes in the research and development of novel compounds aimed at addressing unmet medical needs related to psychiatric conditions.
Company News
GH Research submitted a complete response to FDA's clinical hold on GH001, with one remaining issue regarding respiratory tract histology in rats. The Phase 2b trial showed a 73% remission rate at 6 months for treatment-resistant depression, with no serious adverse events and promising treatment outcomes.
GH Research (GHRS) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
Shares of Urban Outfitters, Inc. (NASDAQ: URBN) dipped during Wednesday’s session after the company reported third-quarter financial results. Urban Outfitters reported quarterly earnings of 88 cents per share, topping the analyst consensus estimate of 82 cents per share. The company reported record quarterly sales of $1.28 billion which exceeded analyst expectations of $1.26 billion, according to data from Benzinga Pro. Urban Outfitters shares fell 9.9% to $32.73 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers AgileThought, Inc. (NASDAQ: AGIL) shares jumped 206.4% to $0.2514 after gaining 5% on Tuesday. PaxMedica, Inc. (NASDAQ: PXMD) rose 33% to $1.08 as the company announced pricing of $7 million public offering. SciSparc Ltd. (NASDAQ: SPRC) gained 29.5% to $8.25 after the company announced it signed a non-binding letter of intent to merge with a vehicle importer company in Israel. Agape ATP Corporation (NASDAQ: ATPC) climbed 22% to $1.15. Agape ATP announced a $1 million share repurchase plan over the next 6 months. Ryvyl Inc. (NASDAQ: RVYL) rose 21.6% to $3.77. The company recently posted a narrower loss for the third quarter. Heart Test Laboratories, Inc. (NASDAQ: HSCS) shares rose 19.3% to $0.2340. HeartSciences recently announced closing ...